Accretion Pharmaceuticals (NSE:ACCPL) Total Liabilities: ₹219.5 Mil (As of Mar. 2026)


NSE:ACCPL Accretion Pharmaceuticals Ltd NSE:ACCPL
30 GF Score
Price ₹159.00
! 6 Warning Signs
View Full Analysis

What is Accretion Pharmaceuticals Total Liabilities?

Accretion Pharmaceuticals NSE:ACCPL +2.15% 30 Total Liabilities is ₹219.5 Mil as of Mar. 2026. GuruFocus rates NSE:ACCPL with a GF Score™ of 30/100. The stock has 6 warning signs investors should review.

Accretion Pharmaceuticals's Total Liabilities for the quarter that ended in Mar. 2026 was ₹219.5 Mil.

Accretion Pharmaceuticals's quarterly Total Liabilities increased from Mar. 2025 (₹0.00 Mil) to Sep. 2025 (₹124.96 Mil) and increased from Sep. 2025 (₹124.96 Mil) to Mar. 2026 (₹219.47 Mil).

Accretion Pharmaceuticals's annual Total Liabilities declined from Mar. 2024 (₹216.99 Mil) to Mar. 2025 (₹0.00 Mil) but then increased from Mar. 2025 (₹0.00 Mil) to Mar. 2026 (₹219.47 Mil).

Accretion Pharmaceuticals Total Liabilities Historical Data

* Premium members only.

The historical data trend for Accretion Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accretion Pharmaceuticals Total Liabilities Chart

Accretion Pharmaceuticals Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
146.65 167.37 216.99 0.00 219.47

Accretion Pharmaceuticals Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Liabilities Get a 7-Day Free Trial 216.99 0.00 0.00 124.96 219.47
NSE:ACCPL
30GF Score
Accretion Pharmaceuticals Ltd NSE:ACCPL
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accretion Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Accretion Pharmaceuticals's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=208.121+(8.625+2.724
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=219.5

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=766.555-547.085
=219.5

Accretion Pharmaceuticals's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=208.121+(8.625+2.724
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=219.5

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=766.555-547.085
=219.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹219.5 Mil mean?
Accretion Pharmaceuticals (NSE:ACCPL) has a Total Liabilities of ₹219.5 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Accretion Pharmaceuticals and its competitors.
Is Accretion Pharmaceuticals' Total Liabilities too high?
Accretion Pharmaceuticals' current Total Liabilities is ₹219.5 Mil. Overall, Accretion Pharmaceuticals has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Accretion Pharmaceuticals' Total Liabilities compare to LLY and JNJ?
Accretion Pharmaceuticals' Total Liabilities of ₹219.5 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Accretion Pharmaceuticals and its competitors. Accretion Pharmaceuticals's current Total Liabilities is ₹219.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accretion Pharmaceuticals stock overvalued right now?
Accretion Pharmaceuticals (NSE:ACCPL) has a current Total Liabilities of ₹219.5 Mil. The current Total Liabilities is ₹219.5 Mil. Accretion Pharmaceuticals' overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Accretion Pharmaceuticals (NSE:ACCPL), the current Total Liabilities is ₹219.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accretion Pharmaceuticals Business Description

Address 29, Xcelon Industrial Park-1, Behind Intas Pharmaceuticals, Vasna-Chacharwadi, Ta - Sanand District, Ahmedabad, GJ, IND, 382213
Accretion Pharmaceuticals Ltd is engaged in the manufacturing of Medicinal & Pharmaceutical Products. The company manufactures tablets, oral liquid, capsule, cream, ointment, mouthwash, dusting powder, gel, ear drops, lotion, shampoo, powder, syrup, among others.
30GF Score

Get the complete analysis for NSE:ACCPL

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹159.00
Price